These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5885069)

  • 1. Sulfamylurea hypoglycemic agents. I. Synthesis and screening.
    McManus JM; McFarland JW; Gerber CF; McLamore WM; Laubach GD
    J Med Chem; 1965 Nov; 8(6):766-76. PubMed ID: 5885069
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfamylurea hypoglycemic agents. 3. Tetrasubstituted sulfamylureas and N-sulfamylcarbamates.
    McFarland JW; Gerber CF; McLamore WM
    J Med Chem; 1965 Nov; 8(6):781-4. PubMed ID: 5885071
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug research on norbornane-derivatives. 3].
    Krieger H
    Arzneimittelforschung; 1968 Apr; 18(4):487-93 concl. PubMed ID: 4177248
    [No Abstract]   [Full Text] [Related]  

  • 4. [New compounds and reactions of sulfonamides with amines. XIV. Hypoglycemic properties of some derivatives of N-(benzenosulfonyl)-delta-2-pyrazoline-1-carboxamide].
    Brzozowski Z; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1974; 31(5):601-6. PubMed ID: 4447012
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypoglycemic quinoline-8-carboxamide benzene sulfonamide derivatives].
    Weyer R; Aumüller W; Bänder A; Heerdt R; Pfaff W; Schweitzer R; Weber H
    Arzneimittelforschung; 1974 Mar; 24(3):269-75. PubMed ID: 4407407
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfamylurea hypoglycemic agents. II. Drug dynamic studies.
    Wiseman EH; Pereira JN; Finger KF; Pinson R
    J Med Chem; 1965 Nov; 8(6):777-81. PubMed ID: 5885070
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel series of N-(1-aminoalkylidene)carboximidamides as potential hypoglycemic agents.
    Breslin HJ; Kukla MJ; Tuman RW; Rebarchak MC; Bowden CR
    J Med Chem; 1993 May; 36(11):1597-603. PubMed ID: 8496927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution to the study of central and peripheral cholinergics and anticholinergics. VII. Several structural analoques of oxotremorine of its homologues and their iodomethylates].
    Levy J; Michel-Ber E; Fumagalli N; Gotti MB
    Therapie; 1967; 22(6):1461-75. PubMed ID: 5587483
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
    Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral effect of new urea derivatives with hypoglycemic action].
    CANAL N; GARATTINI S; TESSARI L
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):491-4. PubMed ID: 13374139
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypoglycemic action of sulfonamide compounds].
    BUTTURINI U
    G Clin Med; 1956 Sep; 37(9):1217-48. PubMed ID: 13384740
    [No Abstract]   [Full Text] [Related]  

  • 12. [New compounds and reactions of sulfonamides with amines. XV. Synthesis and hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-3,5-diethyl-5-methyl-2-pyrazoline-1-carbonamide].
    Brzozowski Z; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(3):301-5. PubMed ID: 941694
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypoglycemic activity of derivatives of succinic acid amides and hydrazides].
    Dolzhenko AV; Kotegov VP; Godina AT; Syropiatov BIa; Kolotova NV; Koz'minykh VO
    Eksp Klin Farmakol; 2003; 66(3):36-8. PubMed ID: 12924231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents.
    Humphries PS; Bersot R; Kincaid J; Mabery E; McCluskie K; Park T; Renner T; Riegler E; Steinfeld T; Turtle ED; Wei ZL; Willis E
    Bioorg Med Chem Lett; 2018 Feb; 28(3):293-297. PubMed ID: 29292223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemic sulfonylureas in various types of experimental diabetes.
    BUSE JF; GORDON MF; LUKENS FD
    Diabetes; 1957; 6(1):7-12; discussion, 19-20. PubMed ID: 13397410
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct, metal-free amination of heterocyclic amides/ureas with NH-heterocycles and N-substituted anilines in POCl3.
    Deng X; Roessler A; Brdar I; Faessler R; Wu J; Sales ZS; Mani NS
    J Org Chem; 2011 Oct; 76(20):8262-9. PubMed ID: 21899258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic actions of tolbutamide and carbutamide.
    TUCKER BW; WILLIAMS RH
    Metabolism; 1956 Nov; 5(6 Part 2):801-6. PubMed ID: 13378049
    [No Abstract]   [Full Text] [Related]  

  • 18. Piperidine-based heterocyclic oxalyl amides as potent p38 alpha MAP kinase inhibitors.
    Mavunkel BJ; Perumattam JJ; Tan X; Luedtke GR; Lu Q; Lim D; Kizer D; Dugar S; Chakravarty S; Xu YJ; Jung J; Liclican A; Levy DE; Tabora J
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1059-62. PubMed ID: 20031411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypoglycemic sulfonamides].
    Loubatières AL
    Actual Pharmacol (Paris); 1968; 21():173-90. PubMed ID: 4888764
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulfamylurea hypoglycemic agents. 6. High-potency derivatives.
    Sarges R; Kuhla DE; Wiedermann HE; Mayhew DA
    J Med Chem; 1976 May; 19(5):695-709. PubMed ID: 1271411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.